Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Mayo Clinic Proceedings
|
May 1, 1976
Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis
F Kueppers, E R Dickson, W H Summerskill
Clinical Pharmacokinetics
|
September 1, 1982
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease
M Uribe, W H Summerskill, V L Go
Lancet (London, England)
|
December 25, 1971
Transport of urea and ammonia production in the human colon
E Wolpert, S F Phillips, W H Summerskill
The New England Journal of Medicine
|
August 14, 1975
Letter: Gallbladder function in nontropical sprue
E P DiMagno, V L Go, W H Summerskill
Gastroenterology
|
May 1, 1976
Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease
N F LaRusso, W H Summerskill, J T McCall
The Journal of Laboratory and Clinical Medicine
|
April 1, 1971
Radioimmunoassay of porcine cholecystokinin-pancreozymin
V L Go, R J Ryan, W H Summerskill
Gastroenterology
|
May 1, 1977
Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone
S W Schalm, W H Summerskill, V L Go
Digestive Diseases and Sciences
|
February 1, 1979
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals
J R Malagelada, V L Go, W H Summerskill
Gastroenterology
|
September 1, 1976
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome
A P Geubel, A H Baggenstoss, W H Summerskill
Gastroenterology
|
October 1, 1979
Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisone
A J Czaja, A M Wolf, W H Summerskill
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Mayo Clinic Proceedings
|
May 1, 1976
Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis
F Kueppers, E R Dickson, W H Summerskill
Clinical Pharmacokinetics
|
September 1, 1982
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease
M Uribe, W H Summerskill, V L Go
Lancet (London, England)
|
December 25, 1971
Transport of urea and ammonia production in the human colon
E Wolpert, S F Phillips, W H Summerskill
The New England Journal of Medicine
|
August 14, 1975
Letter: Gallbladder function in nontropical sprue
E P DiMagno, V L Go, W H Summerskill
Gastroenterology
|
May 1, 1976
Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease
N F LaRusso, W H Summerskill, J T McCall
The Journal of Laboratory and Clinical Medicine
|
April 1, 1971
Radioimmunoassay of porcine cholecystokinin-pancreozymin
V L Go, R J Ryan, W H Summerskill
Gastroenterology
|
May 1, 1977
Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone
S W Schalm, W H Summerskill, V L Go
Digestive Diseases and Sciences
|
February 1, 1979
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals
J R Malagelada, V L Go, W H Summerskill
Gastroenterology
|
September 1, 1976
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome
A P Geubel, A H Baggenstoss, W H Summerskill
Gastroenterology
|
October 1, 1979
Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisone
A J Czaja, A M Wolf, W H Summerskill
Page
of 8